Ticagrelor
|
|
Ticagrelor 속성
- 끓는 점
- 362.8±42.0 °C(Predicted)
- 밀도
- 1.19±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 7.67±0.60(Predicted)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Danger | ||||||||||||||||||||||||||||
유해·위험 문구: |
|
||||||||||||||||||||||||||||
예방조치문구: |
|
Ticagrelor 공급 업체
글로벌( 25)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14335 | 58 |
BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19553 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3149 | 58 |
Shanghai Payne Pharmaceutical Technology Co.Ltd | 021-58123769 18678586262 |
info@paynepharm.com | China | 1354 | 58 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 |
sales@bjcomparison.com | China | 4919 | 58 |
Bide Pharmatech Ltd. | 400-164-7117 13681763483 |
product02@bidepharm.com | China | 41463 | 60 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 15185 | 58 |
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. | 15633056635 |
2880679888@qq.com | China | 2881 | 58 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8346 | 55 |
Anhui Feixiang Pharmaceutical Technology Co., Ltd. | 13349001619 |
sales@feixiangpharm.com | China | 1008 | 58 |
Ticagrelor 관련 검색:
Ticagrelor Sulfone
Ticagrelor diastereoMer
TICAGRELOR
Ticagrelor Related Compound 90 HCl
Ticagrelor Related Compound 44
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid
N-[(3aS,4R,6S,6aR)-Tetrahydro-6-(2-hydroxyethoxy)-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamic acid phenylmethyl ester
AR-C 124910XX
Ticagrelor Related Compound 4 (6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1.3-dioxol-4-ol)
3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-
4H-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]
triazolo[4,5-d]pyrimidin-7-ol
Ticagrelor Impurity 15
2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol
2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide
(1S,2R)-2-(4-fluorophenyl)cyclopropanamine hydrochloride
Ticagrelor Sulphone
Ticagrelor Related Compound 3 ((+/-)-6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1.3-dioxol-4-ol)